X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
stroke (15) 15
atrial fibrillation (14) 14
index medicus (13) 13
female (11) 11
humans (11) 11
male (11) 11
aged (10) 10
cardiac & cardiovascular systems (10) 10
management (10) 10
middle aged (9) 9
risk factors (8) 8
hemorrhage (7) 7
mortality (7) 7
patients (7) 7
therapy (7) 7
prospective studies (6) 6
warfarin (6) 6
aged, 80 and over (5) 5
atrial fibrillation - drug therapy (5) 5
care and treatment (5) 5
guidelines (5) 5
prevention (5) 5
registries (5) 5
anticoagulants (4) 4
anticoagulants - therapeutic use (4) 4
anticoagulation (4) 4
drug therapy (4) 4
medicine, general & internal (4) 4
prevalence (4) 4
risk (4) 4
risk assessment (4) 4
stroke - prevention & control (4) 4
stroke prevention (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
acute coronary syndromes (3) 3
age (3) 3
analysis (3) 3
anticoagulants - adverse effects (3) 3
antiplatelet therapy (3) 3
arrhythmia (3) 3
atrial fibrillation - complications (3) 3
atrial fibrillation - diagnosis (3) 3
atrial fibrillation - epidemiology (3) 3
atrial fibrillation - mortality (3) 3
bleeding (3) 3
cardiovascular system (3) 3
clinical neurology (3) 3
diagnosis (3) 3
garfield-af (3) 3
hemorrhage - chemically induced (3) 3
international normalized ratio (3) 3
kaplan-meier estimate (3) 3
meta-analysis (3) 3
oral anticoagulation (3) 3
outcomes (3) 3
registry (3) 3
studies (3) 3
thromboembolism (3) 3
time factors (3) 3
usage (3) 3
vitamin k - antagonists & inhibitors (3) 3
1506 (2) 2
agronomy (2) 2
antagonists (2) 2
anticoagulant therapy (2) 2
antimicrobial activity (2) 2
antioxidants (2) 2
antithrombotic therapy (2) 2
antithrombotic treatment (2) 2
antithrombotic treatment patterns (2) 2
ascorbic-acid (2) 2
aspirin (2) 2
biology and life sciences (2) 2
blood pressure (2) 2
cardiac arrhythmia (2) 2
cardiology (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - mortality (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebral blood flow (2) 2
cerebral infarction (2) 2
chemistry (2) 2
chloroplasts (2) 2
chronic kidney disease (2) 2
clinical trials (2) 2
collaboration (2) 2
computed tomography (2) 2
death (2) 2
diagnostic medicine (2) 2
disease incidence (2) 2
dosage and administration (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
electrocardiography (2) 2
embolism (2) 2
esc guidelines (2) 2
euro heart survey (2) 2
fibrillation (2) 2
fibrinolytic agents - adverse effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article